Notice
MAVIS edition 102
Marketing Authorisations Veterinary Information Service (MAVIS) edition 102
Documents
Details
Content of MAVIS 102:
- Pharmaceutical Industry Information Event on 23 June 2017
- Restrictions on Schedule 6 (Exemptions for small pet animals) active substances
- Guidance for applicants regarding applications to be submitted under Article 13
- Marketing Authorisations
- Quarterly reporting against VMD Published Standards for 2016-17 licensing work
- Top Ten Imported Veterinary Medicines Quarterly Report from 1 January to 31 March 2017
- Good Manufacturing Practice Inspection Team (GMPIT)
- GMPIT inspection deficiency classification
- GMPIT inspection deficiency findings 1 April 2016 to 31 March 2017
- The Inspections and Investigations Team (IIT)
- Changes to Wholesale Dealer Authorisation (WDA) application and variation forms
- Pharmacovigilance quarterly report
- Enforcement
- Antimicrobial Resistance
- Veterinary Products Committee
- Residues controls and monitoring
- Staff changes
- VMD organogram as at 1 April 2017